UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Court suspends FSC’s disciplinary action against Samsung BioLogics
The Seoul Administrative Court Tuesday suspended the Financial Services Com...
by Lee Han-soo
|
2019-02-20 12:12
라인
Chong Kun Dang unveils trial results for erectile dysfunction treatment
Chong Kun Dang said Monday that it has presented the clinical trial results...
by Lee Han-soo
|
2019-02-19 17:36
라인
Yuhan’s sales reached ₩1.5 trillion in 2018
Yuhan Corp. said Monday that it recorded 1.5 trillion won ($1.3 billion) in...
by Lee Han-soo
|
2019-02-19 16:06
라인
Pharma Research Bio wins nod to export botulinum toxin
Pharma Research Bio said it obtained approval from the Ministry of Food and...
by Lee Hye-seon
|
2019-02-19 15:46
라인
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
Whether MSD’s ertugliflozin, a new antidiabetic SGLT-2 (sodium-glucose cotr...
by Kim Yun-mi
|
2019-02-19 14:31
라인
Does anticoagulant Eliquis work on children?
The Ministry of Food and Drug Safety has allowed BMS Korea to conduct a pha...
by Lee Hye-seon
|
2019-02-19 10:53
라인
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test
Handok said Monday that it has signed an agreement with Technoclone, an Aus...
by Lee Han-soo
|
2019-02-18 16:38
라인
‘Hair loss drug Propesia works well for Koreans in long term’
MSD Korea’s Propesia (ingredient: finasteride), which has been used as male...
by Kim Yun-mi
|
2019-02-18 16:38
라인
Hanmi’s RaboneD dominates osteoporosis therapy market
Hanmi Pharmaceutical’s RaboneD, an osteoporosis treatment in the selective ...
by Kim Yun-mi
|
2019-02-18 14:23
라인
Humedix posts record-high sales in Q4 sales
Humedix said Friday that its earnings turned around and has posted record-h...
by Lee Han-soo
|
2019-02-18 14:22
라인
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
Peptron said Monday that the Ministry of Food and Drug Safety has approved ...
by Lee Han-soo
|
2019-02-18 11:13
라인
Sillajen’s research selected as cover paper for international journal
Sillajen said Friday that the Clinical Cancer Research, an international jo...
by Lee Han-soo
|
2019-02-15 17:36
라인
SK Biopharmaceuticals, Arvelle to develop, commercialize cenobamate in Europe
SK Biopharmaceuticals said Thursday that it has signed an exclusive licensi...
by Lee Han-soo
|
2019-02-15 15:36
라인
Acute myeloid leukemia treatment Rydapt approved as orphan drug
The regulatory agency approved Rydapt 25mg (ingredient: midostaurin), a tre...
by Lee Hye-seon
|
2019-02-15 15:36
라인
Sanofi Genzyme Korea launches rare blood disorder franchise
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has lau...
by Lee Han-soo
|
2019-02-15 14:37
라인
GC starts P2 trials of hepatitis B treatment
GC said Thursday that it has administered the first dose of GC1102, a new r...
by Lee Han-soo
|
2019-02-15 14:36
라인
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
MSD took the No. 1 position in sales of antidiabetic dipeptidyl peptidase-4...
by Kim Yun-mi
|
2019-02-15 14:31
라인
Dong-A ST posts ₩567.2 billion in 2018 sales
Dong-A ST said Wednesday that it recorded the sales of 567.2 billion ($504....
by Lee Han-soo
|
2019-02-14 16:13
라인
Blood-thinning NOAC market expands 30% in 2018
The domestic market of non-vitamin K antagonist oral anticoagulants (NOAC) ...
by Kim Yun-mi
|
2019-02-14 12:12
라인
Yuhan’s subsidiary wins ₩43.5 billion funding
ImmuneOncia Therapeutics said Wednesday that it has completed a private equ...
by Lee Han-soo
|
2019-02-13 17:04
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top